The Far-Reaching Ripple Effects of a Discredited Cancer Study
A flawed study attracted grants, investments and other researchers who based new work on the faulty findings.
- Emily Unleashed
- Alzheimers And Dementia
- Broken Framework
- Cancer And Hematology Research
- Cardiac Health And Statins
- Climate Science
- Covid-19
- Emily Unleashed
- Epidemiology
- Featured Content
- Health and Medicine
- History of Modern Science
- Irrationalism
- Nutrition
- Original Content
- P Values And Hypothesis Testing
- Podcast Episodes
- Postmodernism
- Probability Theory
- Problems with Peer Review
- Psychiatric And Psychology
- Public Health
- Scientific Misconduct
- Significance Testing
- Speaking Series
- Statins
- Video
- Women's Health
Emily Unleashed: Show Trailer
Coming August 28th! This episodic series from BSI’s Emily Kaplan aims to change our collective conversation through art and science.
Thomas Seyfried’s latest Research Explained
Bob Kaplan gives a background of the MMT theory of cancer explains the importance of Thomas Seyfried’s latest work.
Treating Pancreatic Cancer: Could Metabolism—Not Genomics—Be the Key?
Despite the expansion of the field of cancer genomics, Thomas Seyfried maintains that the metabolic view offers a better explanation for the cause, and better solutions for the treatment of cancers.
Cancer risk assessment, its wretched history and what it means for public health
From corruption in governing bodies to deliberate misrepresentations by researchers, this series takes the first steps to correct the scientific record in the field of cancer risk.
Dana-Farber Cancer Institute Researchers Accused of Manipulating Data
Four senior researchers at Harvard’s Dana-Farber Cancer Institute have been accused of forging data through “duplications of blots, bands, and plots within images.”
Raise Standards for Preclinical Cancer Research
Efforts over the past decade to characterize the genetic alterations in human cancers have led to a better understanding of […]
Have cancer deaths dropped by a third over the last three decades?
Investigators and the media need to be more careful interpreting and reporting “cancer mortality”
